Literature DB >> 33491282

Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium-induced colitis in mice.

Haiyan Chen1,2, Liubo Chen1, Xin Wang3, Xiaoxu Ge1, Lifeng Sun1, Zhanhuai Wang1,4, Xiaoming Xu4,5, Yongmao Song1,4, Jing Chen1, Qun Deng1,4, Haiting Xie1,4, Ting Chen6, Yan Chen4, Kefeng Ding1,4, Jingjing Wu3, Jian Wang1,4.   

Abstract

Integrins, as a large family of cell adhesion molecules, play a crucial role in maintaining intestinal homeostasis. In inflammatory bowel disease (IBD), homeostasis is disrupted. Integrin αvβ6, which is mainly regulated by the integrin β6 subunit gene (ITGB6), is a cell adhesion molecule that mediates cell-cell and cell-matrix interactions. However, the role of ITGB6 in the pathogenesis of IBD remains elusive. In this study, we found that ITGB6 was markedly upregulated in inflamed intestinal tissues from patients with IBD. Then, we generated an intestinal epithelial cell-specific ITGB6 transgenic mouse model. Conditional ITGB6 transgene expression exacerbated experimental colitis in mouse models of acute and chronic dextran sulphate sodium (DSS)-induced colitis. Survival analyses revealed that ITGB6 transgene expression correlated with poor prognosis in DSS-induced colitis. Furthermore, our data indicated that ITGB6 transgene expression increased macrophages infiltration, pro-inflammatory cytokines secretion, integrin ligands expression and Stat1 signalling pathway activation. Collectively, our findings revealed a previously unknown role of ITGB6 in IBD and highlighted the possibility of ITGB6 as a diagnostic marker and therapeutic target for IBD.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  DSS-induced colitis; IBD; integrin αvβ6

Year:  2021        PMID: 33491282      PMCID: PMC7933932          DOI: 10.1111/jcmm.16297

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  51 in total

1.  PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6.

Authors:  Jian Wang; Jingjing Wu; Jianguo Hong; Rong Chen; Kesen Xu; Weibo Niu; Cheng Peng; Enyu Liu; Jiayong Wang; Song Liu; Michael Agrez; Jun Niu
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

Review 2.  Integrins and Their Role in Immune Cell Adhesion.

Authors:  Michael L Dustin
Journal:  Cell       Date:  2019-04-02       Impact factor: 41.582

3.  CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions.

Authors:  Benjamin Weber; Leslie Saurer; Mirjam Schenk; Nina Dickgreber; Christoph Mueller
Journal:  Eur J Immunol       Date:  2011-02-11       Impact factor: 5.532

Review 4.  Environmental triggers in IBD: a review of progress and evidence.

Authors:  Ashwin N Ananthakrishnan; Charles N Bernstein; Dimitrios Iliopoulos; Andrew Macpherson; Markus F Neurath; Raja A Raja Ali; Stephan R Vavricka; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

Review 5.  Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review.

Authors:  Uma Mahadevan; Mark S Silverberg
Journal:  Gastroenterology       Date:  2018-03-15       Impact factor: 22.682

6.  Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.

Authors:  Séverine Vermeire; Sharon O'Byrne; Mary Keir; Marna Williams; Timothy T Lu; John C Mansfield; Christopher A Lamb; Brian G Feagan; Julian Panes; Azucena Salas; Daniel C Baumgart; Stefan Schreiber; Iris Dotan; William J Sandborn; Gaik W Tew; Diana Luca; Meina T Tang; Lauri Diehl; Jeffrey Eastham-Anderson; Gert De Hertogh; Clementine Perrier; Jackson G Egen; John A Kirby; Gert van Assche; Paul Rutgeerts
Journal:  Lancet       Date:  2014-05-09       Impact factor: 79.321

Review 7.  Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance.

Authors:  Jonas Mudter; Markus F Neurath
Journal:  Inflamm Bowel Dis       Date:  2007-08       Impact factor: 5.325

8.  The safety of vedolizumab for ulcerative colitis and Crohn's disease.

Authors:  Jean-Frédéric Colombel; Bruce E Sands; Paul Rutgeerts; William Sandborn; Silvio Danese; Geert D'Haens; Remo Panaccione; Edward V Loftus; Serap Sankoh; Irving Fox; Asit Parikh; Catherine Milch; Brihad Abhyankar; Brian G Feagan
Journal:  Gut       Date:  2016-02-18       Impact factor: 23.059

Review 9.  Every step of the way: integrins in cancer progression and metastasis.

Authors:  Hellyeh Hamidi; Johanna Ivaska
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

Review 10.  Integrins as architects of cell behavior.

Authors:  Charles H Streuli
Journal:  Mol Biol Cell       Date:  2016-10-01       Impact factor: 4.138

View more
  1 in total

1.  Transgenic overexpression of ITGB6 in intestinal epithelial cells exacerbates dextran sulfate sodium-induced colitis in mice.

Authors:  Haiyan Chen; Liubo Chen; Xin Wang; Xiaoxu Ge; Lifeng Sun; Zhanhuai Wang; Xiaoming Xu; Yongmao Song; Jing Chen; Qun Deng; Haiting Xie; Ting Chen; Yan Chen; Kefeng Ding; Jingjing Wu; Jian Wang
Journal:  J Cell Mol Med       Date:  2021-01-24       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.